Impact of Phacoemulsification versus combined Phacoemulsification-goniotomy on intraocular pressure in primary open-angle glaucoma patients
Benha Medical Journal • 2022
Publication Information
Authors
Mohamed A Awwad, Hend Helal, Taisir Hamouda, and SohaMoussa Mohamed
Keywords
Goniotomy, Phacoemulsification , IOP, Glaucoma, Medications
Journal
Benha Medical Journal
Publisher
Benha Faculty of Medicine
Volume
2022
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Purpose:
To compare the efficacy and safety of combined phacoemulsification-goniotomy to phacoemulsification alone on intraocular pressure (IOP) primary open-angle glaucoma (POAG) patients.
Design: A comparative retrospective research
Patients and Methods:
The study included 2 groups with POAG & cataracts. Group (Ph) included thirty patients who had phacoemulsification alone; while Group (PhG) included thirty patients who had combined phacoemulsification-goniotomy. They were further divided into severe (Phs and PhGs) and moderate (Phm and PhGm) glaucoma groups depending on the level of glaucoma. We recorded the medicated preoperative IOP, number of glaucoma drops, and postoperative IOP for all patients. We followed up patients for 24 months for IOP and the number of IOP lowering drops. All complications were recorded and managed.
Results:
On the first postoperative week, Group (Ph) recorded a reduction of IOP from 35±0.54 and 33±1.9 to 31±0.83 and 28±1.2 mmHg in groups Phs and Phm, respectively. Therefore, we needed to reintroduce the IOP lowering medications for all patients in group Ph with no significant drop in the number of IOP lowering medications by the 24-month follow-up. In group (PhG), we noted a significant fall in postoperative IOP in the first follow-up week from 34±0.29 and 31±0.9 to 26±1.2 and 14±0.9 mmHg in groups PhGs and PhGm, respectively (P-value
To compare the efficacy and safety of combined phacoemulsification-goniotomy to phacoemulsification alone on intraocular pressure (IOP) primary open-angle glaucoma (POAG) patients.
Design: A comparative retrospective research
Patients and Methods:
The study included 2 groups with POAG & cataracts. Group (Ph) included thirty patients who had phacoemulsification alone; while Group (PhG) included thirty patients who had combined phacoemulsification-goniotomy. They were further divided into severe (Phs and PhGs) and moderate (Phm and PhGm) glaucoma groups depending on the level of glaucoma. We recorded the medicated preoperative IOP, number of glaucoma drops, and postoperative IOP for all patients. We followed up patients for 24 months for IOP and the number of IOP lowering drops. All complications were recorded and managed.
Results:
On the first postoperative week, Group (Ph) recorded a reduction of IOP from 35±0.54 and 33±1.9 to 31±0.83 and 28±1.2 mmHg in groups Phs and Phm, respectively. Therefore, we needed to reintroduce the IOP lowering medications for all patients in group Ph with no significant drop in the number of IOP lowering medications by the 24-month follow-up. In group (PhG), we noted a significant fall in postoperative IOP in the first follow-up week from 34±0.29 and 31±0.9 to 26±1.2 and 14±0.9 mmHg in groups PhGs and PhGm, respectively (P-value
Staff Members - Benha University